[Serotonin and cardiovascular diseases. Pathophysiology and significance of serotonin antagonists]

Dtsch Med Wochenschr. 1992 Apr 30;117(18):710-9. doi: 10.1055/s-2008-1062368.
[Article in German]
No abstract available

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Aged
  • Animals
  • Arterial Occlusive Diseases / drug therapy
  • Arterial Occlusive Diseases / physiopathology
  • Blood Platelets / physiology
  • Cardiovascular Diseases / drug therapy
  • Cardiovascular Diseases / physiopathology*
  • Cerebrovascular Disorders / drug therapy
  • Cerebrovascular Disorders / physiopathology
  • Coronary Artery Bypass
  • Coronary Disease / drug therapy
  • Coronary Disease / physiopathology
  • Coronary Disease / surgery
  • Endothelium, Vascular / physiology
  • Eye Diseases / drug therapy
  • Female
  • Humans
  • Hypercholesterolemia / physiopathology
  • Hypertension / drug therapy
  • Hypertension / physiopathology
  • Ketanserin / therapeutic use
  • Male
  • Rats
  • Serotonin / pharmacology
  • Serotonin / physiology*
  • Serotonin Antagonists / therapeutic use*

Substances

  • Serotonin Antagonists
  • Serotonin
  • Ketanserin